Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan)
Sponsor: Edwards Lifesciences
Summary
A single arm, prospective, open, non-randomized, Japanese multicenter trial to evaluate the safety and effectiveness of the Edwards SAPIEN 3 Transcatheter Heart Valve System (Model: 9600TFX) in the treatment of symptomatic severe aortic stenosis patients on chronic dialysis, who are determined by the heart team to be unable to undergo safe open surgical therapy and have the benefits of the study valve implantation. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.
Official title: A Clinical Trial for Transcatheter Aortic Valve Implantation in Chronic Dialysis Patients With Aortic Valve Stenosis
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
38
Start Date
2016-09
Completion Date
2026-01
Last Updated
2024-09-25
Healthy Volunteers
No
Conditions
Interventions
Transcatheter Aortic Valve Implantation (TAVI)
Implantation of Edwards SAPIEN 3 Transcatheter Heart Valve (Model: 9600TFX) via transfemoral, transapical or transaortic approach.
Locations (2)
Osaka University Hospital
Suita, Osaka, Japan
Keio University Hospital
Shinjuku-Ku, Tokyo, Japan